99% Savings - Buy Just @1 Rs X
Levocetirizine + Montelukast + Ambroxol is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Levocetirizine + Montelukast + Ambroxol is used -
Severe
Moderate
Mild
Common
Is the use of Levocetirizine + Montelukast + Ambroxol safe for pregnant women?
Pregnant women may get severe side effects after taking Levocetirizine + Montelukast + Ambroxol. If you are pregnant, do not take Levocetirizine + Montelukast + Ambroxol without a doctor's advice.
Is the use of Levocetirizine + Montelukast + Ambroxol safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Levocetirizine + Montelukast + Ambroxol. So it is adviced to consult the doctor before using it.
What is the effect of Levocetirizine + Montelukast + Ambroxol on the Kidneys?
Very few cases of side effects of Levocetirizine + Montelukast + Ambroxol on kidney have been reported.
What is the effect of Levocetirizine + Montelukast + Ambroxol on the Liver?
Side effects of Levocetirizine + Montelukast + Ambroxol rarely affect the liver.
What is the effect of Levocetirizine + Montelukast + Ambroxol on the Heart?
Levocetirizine + Montelukast + Ambroxol is rarely harmful for the heart.
Levocetirizine + Montelukast + Ambroxol should not be taken with following medicines due to severe side effects it may cause to patients -
Life Threatening
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Levocetirizine + Montelukast + Ambroxol unless your doctor advises you to do so -
Is this Levocetirizine + Montelukast + Ambroxol habit forming or addictive?
No, there is no any evidence that Levocetirizine + Montelukast + Ambroxol is addictive.
Interaction between Food and Levocetirizine + Montelukast + Ambroxol
Due to the absence of research, it is difficult to say how Levocetirizine + Montelukast + Ambroxol and food will interact.
Interaction between Alcohol and Levocetirizine + Montelukast + Ambroxol
No research has been done on this till date. Therefore, it is not known what the effect of taking Levocetirizine + Montelukast + Ambroxol with alcohol will be.
No, Levocetirizine + Montelukast + Ambroxol is not a decongestant. It is an antihistamine, used to relieve symptoms of allergic rhinitis, urticaria, runny nose, itching eyes/nose, and sneezing.
Absorption of Levocetirizine + Montelukast + Ambroxol is not affected by food and hence can be taken with or without food. Preferably it should be taken in the evening. However, you are recommended to take it as per the doctor's instructions.
Yes, Levocetirizine + Montelukast + Ambroxol can be taken with paracetamol. No harmful drug interaction has been reported between them. However, if you feel any unpleasant effects then consult your doctor.
Levocetirizine + Montelukast + Ambroxol is a prescription drug so do not take it without a consulting doctor. It can be harmful for the patient to take this medicine without a doctor's recommendation.
Yes, Levocetirizine + Montelukast + Ambroxol can be taken with montelukast. As per clinical studies, no harmful interaction has been reported after taking them. However, do not take it without doctors advise. A fixed-dose combination of [Medicinie] and montelukast is available in the market which is used in the treatment of respiratory tract inflammation.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xyzal® (levocetirizine dihydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 164,167
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 873-874
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 228
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Singulair® (montelukast sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Lukair® (montelukast sodium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 219